Rchr
J-GLOBAL ID:201901013287178646   Update date: Oct. 25, 2021

Iwasa Motoh

イワサ モトオ | Iwasa Motoh
Affiliation and department:
Research field  (1): Gastroenterology
Papers (143):
  • Yasuhiko Hamada, Akiko Eguchi, Kyosuke Tanaka, Masaki Katsurahara, Noriyuki Horiki, Misaki Nakamura, Mina Tenpaku, Motoh Iwasa, Masako Ichishi, Masatoshi Watanabe, et al. Plexin domain containing protein 2 is more expressed within the invasive area of human colorectal cancer tissues. Human cell. 2021. 34. 5. 1580-1583
  • Tatsunori Hanai, Atsushi Hiraoka, Makoto Shiraki, Ryosuke Sugimoto, Nobuhito Taniki, Akira Hiramatsu, Nobuhiro Nakamoto, Motoh Iwasa, Kazuaki Chayama, Masahito Shimizu. Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan. Journal of clinical medicine. 2021. 10. 15
  • Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi, Ryuta Shigefuku, Yoshihiro Kamada, Eiji Miyoshi, Yoshiyuki Takei. Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy. JGH open : an open access journal of gastroenterology and hepatology. 2021. 5. 7. 827-830
  • Yasuteru Kondo, Motoh Iwasa, Hideto Kawaratani, Hisamitsu Miyaaki, Tatsunori Hanai, Kazuyoshi Kon, Hirotaka Hirano, Masahito Shimizu, Hitoshi Yoshiji, Kiwamu Okita, et al. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study. Hepatology research : the official journal of the Japan Society of Hepatology. 2021. 51. 6. 674-681
  • Akiko Eguchi, Motoh Iwasa, Yasuyuki Tamai, Mina Tempaku, Shinji Takamatsu, Eiji Miyoshi, Hiroshi Hasegawa, Yoshinao Kobayashi, Yoshiyuki Takei. Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein, toll-like receptor 4, and signal transducer and activator of transcription 3, as well as Enterococcus faecalis translocation. Nutrition (Burbank, Los Angeles County, Calif.). 2021. 86. 111194-111194
more...
MISC (470):
Lectures and oral presentations  (76):
  • 慢性腎臓病を有するC型慢性肝炎患者に対するダクラタスビル+アスナプレビル併用療法の腎機能の検討
    (肝臓 2019)
  • 補体因子C1qレベルは慢性肝疾患患者の生存率を規定する新規バイオマーカーである
    (肝臓 2019)
  • カルニチンおよびBCAAは肝硬変ラット肝で上昇する過酸化脂質抑制とミトコンドリア機能改善を介して肝臓を保護する
    (肝臓 2019)
  • 保険診療下におけるパンジェノ型抗HCV治療の効果と安全性 多施設共同研究(第2報)
    (肝臓 2019)
  • 胆汁酸のNAFLDにおける骨格筋量との相関および筋原細胞に及ぼす影響
    (肝臓 2019)
more...
Association Membership(s) (4):
JAPAN SOCIETY OF METABOLISM AND CLINICAL NUTRITION ,  The Japan Society of Hepatology ,  The Japanese Society of Gastroenterology ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page